| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 03/22/2007 | WO2007032466A1 Heterocyclic compound, and production process and use thereof |
| 03/22/2007 | WO2007032445A1 Protein kinase inhibitors |
| 03/22/2007 | WO2006102990A3 Tablet containing steroid hormones |
| 03/22/2007 | WO2006096079A3 Pharmaceutical composition comprising a biosynthetic analog of human insulin, and its use in the treatment of diabetes mellitus. |
| 03/22/2007 | US20070066823 CCR9 inhibitors and methods of use thereof |
| 03/22/2007 | US20070066528 Methods and compositions for treating polycystic ovary syndrome |
| 03/22/2007 | US20070065493 External patch containing estrogen and/or progestogen |
| 03/22/2007 | US20070065371 Novel Dry Powder Inhalation System For Transpulmonary Administration |
| 03/22/2007 | CA2622605A1 Heterocycle compound, and production process and application thereof |
| 03/22/2007 | CA2622021A1 Composition comprising a dendrimer and the use thereof for binding phosphate |
| 03/22/2007 | CA2621292A1 1-2-dihydroquinoline derivative having glucocorticoid receptor binding actvity |
| 03/21/2007 | EP1764110A1 Compositions comprising an insulin sensitivity enhancer and a biguanide |
| 03/21/2007 | EP1764091A2 Improvements in or relating to amphoteric liposomes |
| 03/21/2007 | EP1763534A1 NOVEL 2-SUBSTITUTED D-HOMO-ESTRA-1,3,5(10)-TRIENES AS INHIBITORS OF 17ß-HYDROXYSTEROID DEHYDROGENASE TYPE 1 |
| 03/21/2007 | EP1763530A1 Imidazopyridazine diones, the production thereof, and the use of the same as a medicament |
| 03/21/2007 | EP1569643A4 Use of peroxisome proliferator activated receptor (ppar)-gamma ligands as a treatment for pituitary tumors and associated conditions, such as cushing's syndrome |
| 03/21/2007 | EP1216024B1 Formulation for menopausal women |
| 03/21/2007 | CN1931319A Medicine for treating female climacteric syndrome and endocrine disorder and its prepn process |
| 03/21/2007 | CN1305893C Improved synthesis of cyproterone acetate |
| 03/21/2007 | CN1305890C 17a-fluoroalkyl steroids method for producing the same and pharmaceutical compositions containing said compounds |
| 03/21/2007 | CN1305850C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 03/20/2007 | US7192963 Janus Kinase 3 inhibitors; organ transplant rejection, xeno transplation, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, Crohn's disease, Alzheimer's disease, leukemia, and autoimmune diseases |
| 03/20/2007 | US7192961 1-Carbonyl-4-(4-quinoline-)-piperazine or 1-carbonyl-4-[4-(1H-quinolin-2-{thio}one)-piperazine derivatives; retinopathy, adult respiratory distress syndrome, asthma, osteoarthritis, glomerulonephritis, psoriasis, rheumatoid arthritis, and toxic shock syndrome treatment |
| 03/20/2007 | US7192956 Inducing contraception by delivering to a female of child-bearing age a selective estrogen receptor modulator comprising cyclothiocarbamate derivative |
| 03/20/2007 | US7192955 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/20/2007 | US7192942 Wet milling while crystallizing to obtain a primary particle suspension. |
| 03/20/2007 | US7192929 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 03/20/2007 | US7192570 Compositions of somatostatin analogues |
| 03/15/2007 | WO2007029847A1 Bicyclic aromatic substituted pyridone derivative |
| 03/15/2007 | WO2006136461A3 Non-steroidal progesterone receptor modulators |
| 03/15/2007 | WO2006134613A3 Novel 5-substituted indole derivatives as dipeptidyl peptidase iv (dpp-iv) inhibitors |
| 03/15/2007 | WO2005110358A3 Film-shaped estriol-containing medicament for oral administration |
| 03/15/2007 | US20070060619 Nicotinamide-based kinase inhibitors |
| 03/15/2007 | US20070060572 e.g., 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine; mitogen-activated protein kinase inhibitor; antiinflammatory agent, autoimmune diseases |
| 03/15/2007 | US20070059384 A ground plant extract of Mascagnia eggersiana, a subspecies, or ecotype; improved peripheral blood flow; few side effects |
| 03/15/2007 | US20070059309 Culturing a host cell transformed with a nucleic acid encoding murine anti-human IFN- alpha monoclonal antibody 9F3; culture product neutralizes all seven of recombinant human IFN- alpha subtypes tested; diseases involving cell overexpression; autoimmune diseases; antidiabetic agents; lupus (SLE) |
| 03/15/2007 | CA2621470A1 Bicyclic aromatic substituted pyridone derivative |
| 03/14/2007 | EP1761497A2 Azadecalin glucocorticoid receptor modulators |
| 03/14/2007 | EP1761252A1 Matrix-controlled transdermal therapeutic system based on an adhesive for administering norelgestromin or the combination thereof with an estrogen |
| 03/14/2007 | EP1761242A2 Film-shaped estriol-containing medicament for oral administration |
| 03/14/2007 | EP1443966B1 Method of preventing or treating benign gynaecological disorders |
| 03/14/2007 | EP1406897B1 Compounds |
| 03/14/2007 | EP1259262B1 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 03/14/2007 | EP1011637B1 Modulation of drug loading in multivesicular liposomes |
| 03/14/2007 | EP0944648B1 Glp-1 derivatives |
| 03/14/2007 | CN1930126A 吡啶酮衍生物 Pyridine derivatives |
| 03/14/2007 | CN1927403A Medicine for promoting pigling growth and improving pigling immunity and preparing method thereof |
| 03/14/2007 | CN1927190A Letrozole transdermal drug administration plaster and its preparation method |
| 03/14/2007 | CN1304424C Compounds with growth hormone releasing properties |
| 03/14/2007 | CN1304383C Benzothiazole derivatives |
| 03/14/2007 | CN1303977C Pro-micelle pharmaceutical compositions |
| 03/14/2007 | CN1303889C American ginseng milk and its confection method |
| 03/13/2007 | US7189854 Reacting 4-(2-hydroxyethyl)piperazine and 2-((2-methyl,6-chloro-pyrimidin-4-yl)-amino),5-(2-chloro,6-methyl-phenyl)thiazole to obtain 2-((2-hydroxyethyl)piperazin-4-yl)-(2-methylpyrimidin-6,4-ylene)amino-),5-(2-chloro,6-methyl-phenyl)thiazole; antiarthritic,-tumor, -carcinogentic agents; immunology |
| 03/13/2007 | US7189820 Antibody for use in the treatment, prevention and diagnosis of cancer, autoimmune, arthritic and graft vs. host diseases |
| 03/13/2007 | US7189812 Comprises maternal protein (MATER) for treatment of infertility and reduced fertility; contraceptives |
| 03/13/2007 | US7189758 2-Benzyl-2-hydroxy-4-methyl-4-phenylpentanoic acid (1-oxo-1,3-dihydroisobenzofuran-5-yl)amide for example; treating type II diabetes, obesity, hypertension, arteriosclerosis, or glaucoma |
| 03/13/2007 | US7189728 Inhibitors of dipeptidyl peptidase IV |
| 03/13/2007 | CA2420895C Method for treating erectile dysfunction and increasing libido in men |
| 03/13/2007 | CA2274314C Insulin-like growth factor i (igf-i) expression system and methods of use |
| 03/08/2007 | WO2007025938A1 Non-steroidal compounds useful as glucocorticoid receptor modulators |
| 03/08/2007 | WO2007025632A2 Nitrooxy derivatives op glucocorticoids |
| 03/08/2007 | WO2007025332A1 A peptide and zinc ion composition for treating diabetes and enhancing immune function |
| 03/08/2007 | WO2006120575A3 Tcr-independent activation of t cells with co-lignation of cd28 and cd81 |
| 03/08/2007 | US20070054895 e.g. 5-Benzyloxy-2-(4-benzyloxy-phenyl)-3-methyl-1H-indole or salts for treating colon cancer |
| 03/08/2007 | US20070054364 Polypeptide variants |
| 03/08/2007 | US20070054312 Human transmembrane proteins |
| 03/08/2007 | US20070053833 Hydrating a leukemia patient; parenterally administering a dose samarium ethylenediaminetetramethylenephosphonic acid (EDTMP); and melphalan, busulfan, and/or cyclophosphamiide; anticarcinogenic, antitumor, and antantiproliferative agents; autoimmune, infectious , metabolic or genetic disorders |
| 03/08/2007 | CA2621229A1 Non-steroidal compounds useful as glucocorticoid receptor modulators |
| 03/08/2007 | CA2621117A1 Steroids nitrooxyderivatives |
| 03/07/2007 | EP1759734A2 Aromatase inhibition to enhance assisted reproduction |
| 03/07/2007 | EP1758597A1 Use of drug combinations for treating insulin resistance |
| 03/07/2007 | EP1406591B1 Pharmaceutical composition for nasal delivery of estradiol and norethisterone |
| 03/07/2007 | EP1381370B1 N-biphenylcarbonyl- and n-phenylpyridylcarbonyl substituted bi- and tricyclic azepines and diazepines as vasopressing agonists |
| 03/07/2007 | EP1352061B9 Method for inhibiting the expression of a target gene |
| 03/07/2007 | EP1333840B1 M. tuberculosis chaperonin 60.1 and uses thereof |
| 03/07/2007 | EP1267885B1 Male contraceptive formulation comprising norethisterone and testosterone undecanoate |
| 03/07/2007 | EP1261622B1 Purified recombinant hlh having a specific bioactivity and process for purification thereof |
| 03/07/2007 | EP1001970B1 Dipeptide derivatives as growth hormone secretagogues |
| 03/06/2007 | US7186864 Trifluoromethyl-substituted nitrogen compounds; treating type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumors, and glaucoma |
| 03/06/2007 | US7186798 Derived from ghrelin polypeptide, labelled with fluorochrome and cysteine; drug screening; high throughput assay |
| 03/06/2007 | US7186797 Stability in blood ; complexing using compound containing phosphate group |
| 03/06/2007 | US7186748 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 03/06/2007 | US7186737 Inhibitors of p38 |
| 03/06/2007 | US7186728 Methylene-4-azasteroids |
| 03/06/2007 | US7186706 For improving health in a woman having elevated sex hormone binding globulin levels, or who is receiving oral estrogen supplementation |
| 03/06/2007 | US7186414 Improved bioavailability; for oral and intracolonic administration |
| 03/06/2007 | US7186413 Hydrogels and water soluble polymeric carriers for drug delivery |
| 03/06/2007 | US7186407 Including claudication and critical limb ischemia, by administering fibroblast growth factor (FGF) in two doses, a single dose administered into each leg of the patient within one hour |
| 03/01/2007 | WO2007024004A1 Phenylpyridone derivative |
| 03/01/2007 | WO2007023880A1 Chemokine production inhibitor |
| 03/01/2007 | WO2007022824A1 Use of non-steroidal progesterone receptor modulators |
| 03/01/2007 | WO2006138347A3 Androgen receptor modulator compounds and methods |
| 03/01/2007 | WO2006127941A9 Amorphous cinacalcet hydrochloride and preparation thereof |
| 03/01/2007 | US20070049540 Oligonucleotide inhibiting the expression of star-binding protein (sbp) gene and method therefor |
| 03/01/2007 | US20070048390 Combination of a lanthanum compound and bone enhancing agent for the treatment of bone diseases |
| 03/01/2007 | US20070048311 ANTI-INTERFERON-alpha ANTIBODIES |
| 03/01/2007 | CA2619770A1 Phenylpyridone derivative |
| 03/01/2007 | CA2612161A1 Use of non-steroidal progesterone receptor modulators |
| 03/01/2007 | CA2610475A1 Derivative prodrugs of ethinyl estradiol |
| 02/28/2007 | EP1757944A1 A method of determining the initial dose of vitamin D compounds |